Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001437749-25-036913
Filing Date
2025-12-04
Accepted
2025-12-04 16:11:39
Documents
1
Period of Report
2025-12-03

Document Format Files

Seq Description Document Type Size
1 FORM 4/A OLIVIER TE BOEKHORST rdgdoc.html 4/A  
1 FORM 4/A OLIVIER TE BOEKHORST rdgdoc.xml 4/A 4826
  Complete submission text file 0001437749-25-036913.txt   6240
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Issuer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address
te Boekhorst Paul Francis Olivier (Reporting) CIK: 0002095704 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-12934 | Film No.: 251549501